ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

 January 25, 2006  Sell to close the Genentech March 90 call option (DWN + CR) at the market. We're taking a loss of approximately 50 percent on this trade.   Read More

January 25, 2006  Buy to open the Chevron (CVX) June 65 call option (CVX + FM). Set a limit to pay no more than $2.60 per option.   Despite slow progress to the contrary, a general state of denial seems to pervade today's world with regard to our energy situation. All the evidence points to energy prices remaining strong for as far as the eye can see. Read More

January 11, 2006  Buy to open the Genentech (DNA) March 90 call option (DWN + CR). Set a limit to pay no more than $5.60 per contract.   Genentech (DNA), the leader in cancer drugs reported earnings after the bell last night. Overall revenue and earnings topped estimates, but investors have focused instead on sales of DNA's key drug Avastin. Read More

January 11, 2006  Sell to close your February Standard and Poor's Depositary Receipts 126 put option (SPY + NV) at the market. Maintain your position in the February Standard and Poor's Depositary Receipts 127 call option (SPY + BW).  Read More